<sup>18</sup>F-AlF-NOTA-Octreotide Outperforms<sup>68</sup>Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter StudyElin Pauwels, Christophe M. Deroose, Frederik Cleeren et al.|Journal of Nuclear Medicine|2022Cited by 74
[18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patientsElin Pauwels, Christophe M. Deroose, Sofie Celen et al.|European Journal of Nuclear Medicine and Molecular Imaging|2022Cited by 23
Evaluation of 18F-FA-4 and 11C-pipzA-4 as radioligands for the in vivo evaluation of the high-affinity choline uptake system.C. Gilissen, Guy Bormans, Tjibbe J. de Groot et al.|PubMed|2003Cited by 8
Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)Mohammed Al‐Qahtani, Daniëlle J. Vugts, Martin Béhé et al.|EJNMMI Radiopharmacy and Chemistry|2021Cited by 1
Highlight selection of radiochemistry and radiopharmacy developments by editorial boardJean N. DaSilva, Sarah Spreckelmeyer, Jeroen J. M. A. Hendrikx et al.|EJNMMI Radiopharmacy and Chemistry|2023Cited by 1